NOTICE TO INVESTORSSubscription Agreement • September 7th, 2022 • Coeptis Therapeutics Inc. • Pharmaceutical preparations • Delaware
The securities of Coeptis Therapeutics, Inc., a Delaware corporation (the “Company”), to which this Subscription Agreement relates, represent an investment that involves a high degree of risk, suitable only for persons who can bear the economic risk for an indefinite period of time and who can afford to lose their entire investments. Investors should further understand that this investment is illiquid and is expected to continue to be illiquid for an indefinite period of time. No public market exists for the securities to which this Subscription Agreement relates.
